86 related articles for article (PubMed ID: 23356132)
1. [Galectines as prognostic factors for the malignant lymphoproliferative diseases].
Sivkovych SO; Kysel'ova OA; Mel'nyk UI; Zubryts'ka TB; Serbin IM
Lik Sprava; 2012; (3-4):19-25. PubMed ID: 23356132
[TBL] [Abstract][Full Text] [Related]
2. Galectin-1: a small protein with major functions.
Camby I; Le Mercier M; Lefranc F; Kiss R
Glycobiology; 2006 Nov; 16(11):137R-157R. PubMed ID: 16840800
[TBL] [Abstract][Full Text] [Related]
3. Tumor galectinology: insights into the complex network of a family of endogenous lectins.
Lahm H; André S; Hoeflich A; Kaltner H; Siebert HC; Sordat B; von der Lieth CW; Wolf E; Gabius HJ
Glycoconj J; 2004; 20(4):227-38. PubMed ID: 15115907
[TBL] [Abstract][Full Text] [Related]
4. [Galectins in hematological malignancies--role, functions and potential therapeutic targets].
Wdowiak K; Spychałowicz W; Fajkis M; Wojnar J
Postepy Hig Med Dosw (Online); 2016 Feb; 70():95-103. PubMed ID: 26943306
[TBL] [Abstract][Full Text] [Related]
5. Regulatory roles of galectins in the immune response.
Liu FT
Int Arch Allergy Immunol; 2005 Apr; 136(4):385-400. PubMed ID: 15775687
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of lymphoid and haematopoietic neoplasms: there's more than biomarker discovery.
Zamò A; Cecconi D
J Proteomics; 2010 Jan; 73(3):508-20. PubMed ID: 19755177
[TBL] [Abstract][Full Text] [Related]
7. Unraveling galectin-1 as a novel therapeutic target for cancer.
Astorgues-Xerri L; Riveiro ME; Tijeras-Raballand A; Serova M; Neuzillet C; Albert S; Raymond E; Faivre S
Cancer Treat Rev; 2014 Mar; 40(2):307-19. PubMed ID: 23953240
[TBL] [Abstract][Full Text] [Related]
8. Intracellular galectins in cancer cells: potential new targets for therapy (Review).
Vladoiu MC; Labrie M; St-Pierre Y
Int J Oncol; 2014 Apr; 44(4):1001-14. PubMed ID: 24452506
[TBL] [Abstract][Full Text] [Related]
9. Galectins in hematological malignancies.
Giordano M; Croci DO; Rabinovich GA
Curr Opin Hematol; 2013 Jul; 20(4):327-35. PubMed ID: 23695449
[TBL] [Abstract][Full Text] [Related]
10. Galectins: structure, function and therapeutic potential.
Yang RY; Rabinovich GA; Liu FT
Expert Rev Mol Med; 2008 Jun; 10():e17. PubMed ID: 18549522
[TBL] [Abstract][Full Text] [Related]
11. [Molecular biology in malignant blood diseases. Clinical applications. Study of immunoglobulin and T-cell receptor genes and molecular analysis of the translocations].
González M; García-Sanz R; Vargas M; Balanzategui A; Chillón MC; Mateos MV; San Miguel JF
Sangre (Barc); 1996 Aug; 41(4):321-34. PubMed ID: 8984674
[No Abstract] [Full Text] [Related]
12. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer.
Moiseeva EV; Rapoport EM; Bovin NV; Miroshnikov AI; Chaadaeva AV; Krasilshschikova MS; Bojenko VK; Bijleveld C; van Dijk JE; Den Otter W
Breast Cancer Res Treat; 2005 Jun; 91(3):227-41. PubMed ID: 15952056
[TBL] [Abstract][Full Text] [Related]
13. [Galectin expression in urological cancer. Diagnostic, prognostic and therapeutic potential].
Waalkes S; Merseburger AS; Simon A; Serth J; Kuczyk MA
Urologe A; 2010 Mar; 49(3):387-91. PubMed ID: 20238481
[TBL] [Abstract][Full Text] [Related]
14. Ligand interactions of the Coprinopsis cinerea galectins.
Walser PJ; Kües U; Aebi M; Künzler M
Fungal Genet Biol; 2005 Apr; 42(4):293-305. PubMed ID: 15749049
[TBL] [Abstract][Full Text] [Related]
15. Galectins: regulators of acute and chronic inflammation.
Liu FT; Rabinovich GA
Ann N Y Acad Sci; 2010 Jan; 1183():158-82. PubMed ID: 20146714
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor γ upregulates galectin-9 and predicts prognosis in intestinal-type gastric cancer.
Cho SJ; Kook MC; Lee JH; Shin JY; Park J; Bae YK; Choi IJ; Ryu KW; Kim YW
Int J Cancer; 2015 Feb; 136(4):810-20. PubMed ID: 24976296
[TBL] [Abstract][Full Text] [Related]
17. Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells.
Glinsky VV; Huflejt ME; Glinsky GV; Deutscher SL; Quinn TP
Cancer Res; 2000 May; 60(10):2584-8. PubMed ID: 10825125
[TBL] [Abstract][Full Text] [Related]
18. TGF-β induces HLA-G expression through inhibiting miR-152 in gastric cancer cells.
Guan Z; Song B; Liu F; Sun D; Wang K; Qu H
J Biomed Sci; 2015 Dec; 22():107. PubMed ID: 26627200
[TBL] [Abstract][Full Text] [Related]
19. Context-dependent multifunctionality of galectin-1: a challenge for defining the lectin as therapeutic target.
Smetana K; André S; Kaltner H; Kopitz J; Gabius HJ
Expert Opin Ther Targets; 2013 Apr; 17(4):379-92. PubMed ID: 23289445
[TBL] [Abstract][Full Text] [Related]
20. Galectins as immunoregulators during infectious processes: from microbial invasion to the resolution of the disease.
Rabinovich GA; Gruppi A
Parasite Immunol; 2005 Apr; 27(4):103-14. PubMed ID: 15910418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
